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Summary The relationship between autocrine interferon (IFN) production and the expression of class I
Major Histocompatibility Complex (MHC) membrane glycoproteins in vitro was investigated in a panel of
murine transformed cells of nonhaemopoietic origin. The panel included 11 cell lines of H-2Kb haplotype
derived from fibrosarcomas, carcinomas and melanoma, and from transformed fibroblasts. IFN activity was
detected in the conditioned medium of nine cell lines; fibrosarcomas were among the high IFN producers,
while the non-producers were a melanoma clone and a lung carcinoma cell line. A significant correlation was
found between IFN production and the expression of H-2K/D glycoproteins, thus suggesting that long-term
maintainment of MHC glycoprotein expression in vitro could be mediated by self produced IFN. Two IFN
producer cell lines, MN/MCA1 and R80/17, were cultured in the presence of a blocking antiserum against
IFN c/p: a significant decrease in H-2b expression was observed, thus indicating the existence of an autocrine
IFN circuit. Taken together these findings suggest that release of IFN is a frequent event among transformed
nonhaemopoietic cells, and that self-produced IFN contributes to the regulation of MHC antigen levels in
solid tumours.
The expression of Major Histocompatibility Complex (MHC)
membrane glycoproteins is frequently impaired in tumours
(Tanaka et al., 1988; Elliott et al., 1989; Gopas et al., 1989).
From the analysis of some published reports we estimate that
up to 50% of all human tumours may have alterations of
class I MHC glycoproteins expression with respect to their
normal counterparts.
The dynamic analysis of the in vitro behaviour of MHC
glycoprotein-positive tumour cells reveals an additional type
of MHC instability: some cell lines show a progressive
decrease in MHC expression during in vitro growth, while
others maintain stable MHC glycoprotein levels. In murine
model systems it has been shown that a high MHC glyco-
protein expression can be induced either by in vitro treatment
with interferons (IFN) (Tanaka et al., 1988) or by in vivo
transplant (Ostrand-Rosenberg & Cohan, 1981; Lollini et al.,
1985). We have suggested that re-expression of MHC prod-
ucts during in vivo culture might be caused by IFN produced
by the host (Lollini et al., 1985). An adjunct to this
hypothesis is that tumour cells retaining MHC expression in
vitro should be independent of host-derived IFN.
The present study was set up to ascertain the frequency of
IFN producers in a panel of murine nonhaemopoietic H-2b
transformed cells ofdiverse origin, and to investigate whether
MHC glycoprotein expression was linked to IFN production,
possibly through autocrine circuits.
Materials and methods
Cells
The cells used in this study are listed in Table I. The cultures
were routinely maintained in Dulbecco's MEM (DMEM)
supplemented with 10% Fetal Calf Serum (FCS) and
antibiotics (10OUml1' penicillin and 100 Igmlm1 strepto-
mycin) at 37'C in a 5% CO2 humidified atmosphere. All
media components were purchased from GIBCO, Paisley,
UK. Cell cultures, routinely monitored for mycoplasma con-
tamination by Hoechst 33258 staining (Chen, 1977), were
found mycoplasma-free.
Immunofluorescence
Cells from 4-day cultures (seeded at concentrations ranging
10,000-40,000 cells cm-2) were characterised for H-2b
glycoprotein expression by means of flow cytometric analysis
(FACStar Plus, Becton Dickinson, Mountain View, CA,
USA) after indirect immunofluorescence performed as des-
cribed (De Giovanni et al., 1991). Monoclonal antibodies
(mAb) directed against H-2Kb (clone H-142-23) and H-2Db
(H-141-31) was obtained from Serotec, Bicester, UK. FITC-
conjugated F(ab)2 anti-mouse Ig were purchased from Tech-
nogenetics, Milano, Italy. Results from individual experi-
ments are shown, but these are representative of at least two
similar experiments.
IFNproduction
IFN production was evaluated by inhibition of the
cytopathic effect of vesicular stomatitis virus on mouse L929
cells in 96-well plates (Yeh et al., 1972) on supernatants
collected from 4-day cultures (seeded as above), concentrated
seven times by rotary evaporator and dialised overnight
against Phosphate-Buffered Saline. Titers are the reciprocal
of the highest dilution inhibiting the cytopathic effect by
50%. An internal laboratory standard calibrated against the
NIH G-002-9 4511 standard was included in each assay in
order to express the titers in international units (IU) ml- '. To
determine the type of IFN produced (a/, or '), culture
supernatants were incubated with AN18, a mAb anti-mouse
IFN-7 (Prat et al., 1984). Block of IFN production was made
possible by the kind gift of a sheep anti-mouse IFN-a/p
serum by Dr F. Belardelli, Rome. Cells were cultured for ten
days in the presence of a 1:100 final dilution of antiserum
(that had a neutralising activity of 1/8 x 104 against 1 unit of
IFN-a/p).
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Table I Origin of cell cultures
Cell Transforming Mouse
culture Origin agent strain Source (reference)
MN/MCAl Fibrosarcomaa 3-methylcholanthrene C 57BL/6 A. Mantovani, Milano, Italy (Giavazzi et al., 1980)
B1O-1 Fibrosarcoma 3-methylcholanthrene C 57BL/10 M.P. Colombo, Milano, Italy (Nanni et al., 1983)
B6.3 Fibrosarcoma 3-methylcholanthrene C 57BL/6 M.P. Colombo, Milano, Italy
R80/17 Fibrosarcomaa 3-methylcholanthrene C 57BL/6 A. Mantovani, Milano, Italy (Bottazzi et al., 1986)
C57SV Embryo fibroblasts SV40 C 57BL/6 G. Trinchieri, Lausanne, CH (Knowles et al., 1979)
KCSV Kidney fibroblasts SV40 C 57BL/6 B.B. Knowles, Philadelphia, USA (Knowles et al., 1979)
B16-A Melanomaa Spontaneous C 57BL/6 A. Mantovani, Milano, Italy (Nanni et al., 1983)
B78H1 B16 mutant clone Spontaneous C 57BL/6 T. Boon, Brussels, Belgium (Graf et al., 1984)
3LL/C Lung carcinoma cloneb Spontaneous C 57BL/6 M. D'Incalci, Milano, Italy
Colon 38 Colon carcinoma 1,2-dimethylhydrazine C 57BL/6 M.P. Colombo, Milano, Italy
aIn vitro culture obtained from solid tumour in our laboratory. bClone derived in our laboratory from Lewis lung carcinoma.
Results
Expression ofH-2Kb and Db glycoproteins in cultured cells
The expression of H-2 class I glycoproteins was investigated
in 11 cell lines of the H-2b haplotype, derived from distinct
tumour histotypes (carcinomas, sarcomas, melanoma) or
transformed by different agents (see Table I). Flow cytomet-
ric analysis (Figure 1) revealed that several cell lines in our
panel expressed low levels of Kb and Db glycoproteins. No
clear relationship was evident between H-2b glycoprotein
levels and transforming agent or tumorigenicity.
As we had available both early (<10) and late (>20) in
vitro passages of cell lines MN/MCA1 and B16-A established
in our laboratory, we evaluated the dynamics of H-2 expres-
sion during in vitro growth. Opposite behaviours were
observed: the expression of H-2b glycoproteins in B16-A cells
was significantly decreased after prolonged in vitro culture,
while MN/MCA1 cells maintained a constantly high level
even after many passages (Figure 2).
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Figure 1 Flow cytometric analysis of H-2Kb (left panels) and
H-2Db (right panels) expression in eleven cell lines at > 10 in
vitro passages. % pos. = percentage of H-2-positive cells of each
culture determined by setting gates so as to exclude 99% of cells
stained with second antibody alone.
IFNproduction
Class I H-2 genes contain IFN-responsive elements, and a
high H-2 glycoprotein expression can be induced in many
transformed cell lines by treatment with IFNs. Therefore we
asked whether an autocrine production of IFN could account
for the high level of H-2 expression maintained by some of
our cell lines.
Four of eleven cell lines, three derived from MCA-induced
tumours and one from SV40-transformed fibroblasts, pro-
duced high levels of IFN (Figure 3); five more supernatants
contained detectable levels. Analogous conclusions were
reached when results were expressed per 107 medium-
conditioning cells, to account for differences in cell yield
among cell lines (Figure 3). Since IFN activity was not
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Figure 2 H-2Kb (left) and H-2Db (right) expression in early and
late in vitro passages of B16-A and MN/MCA1 cells.AUTOCRINE IFN PRODUCTION AND H-2 EXPRESSION 481
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Figure 3 IFN activity evaluated on concentrated conditioned media.
impaired by incubation with AN/18 anti-mouse IFN-y mAb,
therefore it can be ascribed to the presence of IFN-a/,.
Autocrine regulation ofH-2 glycoprotein expression by IFN
When the proportion of H-2-positive cells in each cell line
was plotted as a function of the IFN titer in the supernatant,
a significant correlation emerged (Figure 4).
This finding supports the possibility that IFN production
contributes to long-term maintainment of MHC glycoprotein
expression in vitro. To obtain direct evidence MN/MCAl
and R80/17 cells were cultured in the presence of a blocking
anti-IFN-a/p antibody. The significant decrease in H-2
glycoprotein expression observed (Figure 5) indicates that
interference with autocrine IFN production impairs MHC
glycoprotein expression in a way similar to that observed in
the late in vitro passages of cells that do not produce IFN.
Discussion
In vitro cultured cells frequently show considerable variations
in their expression of MHC gene products (Carbone et al.,
1978; Finn et al., 1978; Nanni et al., 1983). We have shown
here that, in a panel of murine transformed H-2b cells of
diverse origin, production of IFN was a frequent event: nine
of eleven cell lines released IFN-a/P in the culture medium.
In these cells the quantitative expression of H-2 class I
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Figure 4 Regression analysis of the correlation between IFN activity and H-2Kb (left) or H-2Db (right) percentage of positive cells,
evaluated by cytofluorimetric analysis. Each point represents one cell line.
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Figure 5 Decrease of H-2Kb (left) and H-2Db (right) expression
in MN/MCA1 and R80/17 cells cultured in the presence of
antiserum anti-IFN-a/P.
glycoproteins showed a positive correlation with the amount
of IFN produced. Data on cells of a different haplotype
(H-2d) confirm the decrease in H-2 expression by in vitro
cultured cells that do not produce IFN (data not shown).
Moreover, culture of MN/MCA1 or R80/17 cells in the
presence of antibodies against IFN-a/P resulted in a
significant decrease in H-2K/D antigen expression. Therefore,
our data suggest that self-produced IFN contributes to the
regulation of MHC glycoprotein levels in solid tumours.
Data on an additional IFN-inducible gene (Ly-6A/E) are
consistent with the existence of an autocrine loop (manu-
script in preparation). However, we cannot rule out the
possibility that other factors might also be involved.
The highest IFN release was observed among fibrosar-
comas and transformed fibroblasts, while also some non-
mesenchymal cell lines release a detectable IFN activity. A
high IFN production did not appear to be associated with a
slower in vitro growth rate. It is interesting to note that in
vivo tumorigenicity did not correlate with IFN production:
on the basis of IFN units found in their supernatants one
cannot distinguish metastatic fibrosarcomas, like MN/MCA1
and R80/17, and nontumorigenic fibroblasts like C57SV.
Presently we do not know whether a sustained IFN release
is maintained in vivo by tumorigenic cells. A considerable
quantitative heterogeneity was observed within lines: for
example in fibrosarcomas two log decades separated MN/
MCA1 and B6.3. Cloning experiments and selection of
metastatic variants will show whether clonal heterogenity is
present in vitro and whether selective advantages or disadvan-
tages are conferred in vivo by IFN production.
It has been reported that the MHC glycoprotein expression
by human tumours correlates with the extent of lymphocytic
infiltrate (Maudsley & Pound, 1991). It is reasonable to
assume that tumour-infiltrating cells act as a source of IFNs
and of other lymphokines influencing MHC genes. Here we
have investigated only phenomena taking place in vitro, but
we can hypothesise that tumours producing IFN should have
MHC glycoprotein levels independent of their infiltrate. It
must be kept in mind, however, that the in vivo production of
IFN by the tumour cells might vary depending on growth
rate, nutritional status, and also on the interaction with other
IFN-producing cells such as macrophages and lymphoid
cells: we have previously shown that in vivo the antigenic
distance between tumour and host can influence tumour H-2
expression, probably through IFN-i released by T cells (Lol-
lini et al., 1985). Interaction with other cytokines might also
affect MHC expression.
The determination of IFN production by tumour cells
might represent a useful adjunct to the study of MHC ex-
pression in human neoplasms. Mesenchymal tumours appear
to be good candidates to test this hypothesis.
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